切換帳號

  • FAQ
    • 新手指南
    • FAQ常見問題
  • 學術會議
  • 影音網
  • 登入

全站搜尋

台灣泌尿科醫學會E-School
  • 登入
  • FAQ
    • 新手指南
    • FAQ常見問題
  • 學術會議
  • 影音網
  • 到官網
  • Home
  • 到官網
  • Home
知識庫
  • 目錄總覽
  • 文件總覽
  • 最新討論
目錄 / 資料夾
  • 學術活動與演講
    • 年會
      • 2026年會
        • 摘要
      • 2026半年會
        • 摘要
      • 2025年會 (UAA)
        • 摘要
      • 2025半年會
        • 摘要
      • 2024年會
        • 摘要
      • 2024半年會
        • 摘要
      • 2023年會
        • 摘要
      • 2023半年會
        • 摘要
      • 2022年會
        • 摘要
      • 2021年會
        • 摘要
      • 2021半年會
        • 摘要
      • 2020年會
        • 摘要
      • 2020半年會
        • 摘要
      • 2019年會
        • 摘要
      • 2019半年會
        • 摘要
      • 2018年會
        • 摘要
      • 2018半年會
        • 摘要
      • 2017年會
        • 摘要
      • 2017半年會
        • 摘要
      • 2016年會
        • 摘要
      • 2016半年會
        • 摘要
      • 2015年會
        • 摘要
  • 新手指南與FAQ
  1. 知識庫
  2. 熱門媒體

熱門媒體
(
  • 最新
)

熱門媒體

(
  • 最新
)
#0621 Optimal duration of hydrodistension for symptomatic treatment of interstitial cystitis: A systematic review and meta-analysis
139 觀看
#0385 REZUM as treatment for BPH in Australian Public hospitals. A single centre retrospective analysis.
139 觀看
#0738 Randomized Controlled Trial: Effectiveness of Urethral Dilatation in Preventing Stricture Formation Post-Transurethral Resection of the Prostate (TURP)
139 觀看
#1322 Deintensification of androgen receptor pathway inhibitor in metastatic hormone-sensitive prostate cancer: an exploratory study of survival outcomes and predictive factors
139 觀看
#0466 Initial Experience of Robotic-Assisted Laparoscopic Sacrocolpopexy (RASC) Using the Hugo RAS System
139 觀看
#1422 Can Preoperative Shear Wave Elastography Predict the Outcomes of Varicocelectomy in Relation to Semen Parameters and Sperm DNA Fragmentation Index?: Prospective single centre experience
139 觀看
#1107 Comparative Outcomes of First-Line ICI Combination and TKI Monotherapy for Advanced RCC
139 觀看
#1272 Kidney Transplantation In Patients With Small Bladder Capacity: A Single-Center Experience At Cho Ray Hospital In Vietnam.
139 觀看
#1375 Parameters associated with delayed graft function in kidney transplant patients
139 觀看
#1144 Primary versus Sequential MRI for Prostate Cancer Screening: Systematic Review and Meta-analysis
139 觀看
#0540 Validation of the BURST collaborative score for likelihood of spontaneous ureteral calculus passage in an Australian cohort
138 觀看
#0283 Integrating Multi-Cohort Machine Learning and Clinical Validation to Explore Peripheral Blood mRNA Diagnostic Biomarkers for Prostate Cancer
138 觀看
#0705 Long-term oncologic outcomes following laparoscopic radical nephroureterectomy: Contemporary analysis from a Japanese multicenter study
138 觀看
#0780 Evaluation of Risk Factors for Urinary Tract Dilatation in Preterm Infants
138 觀看
#0740 Autologous Dendritic Cell Vaccination as Add-On Therapy Improves Overall Survival in Stage IV Prostate Cancer: A Retrospective Matched Cohort Study
138 觀看
#0912 Endoscopic Enucleation of the Prostate for Benign Prostatic Hyperplasia: Comparable Efficacy Across All Prostate Sizes
138 觀看
#0694 The efficacy of the attenuation value of bladder urine on non-contrast CT for predicting urine culture positivity
138 觀看
#0837 Targeted Pelvic Lymph Node Dissection with SCOUT for Robotic Prostatectomy
138 觀看
#0193 Innovations in Urological Surgery: Evaluating the Effects of Dexamethasone on Pain Management in Ureteral Stone Procedures
137 觀看
#0635 Intraoperative Bilateral Intrarenal Pressure Measurement during Retrograde Intrarenal Surgery: Real-Time Comparison with Normal Contralateral Pressure
137 觀看
#1265 Deep learning-based multi-model prediction for disease-free survival status of patients with clear cell renal cell carcinoma after surgery: a multicenter cohort study
137 觀看
#0515 The Australian Urologic risk Stratification of patientS wIth hEmaturia (AUSSIE) Study of Cxbladder Performance for the Detection of Urothelial Carcinoma in Patients with Hematuria: Trial in Progress
137 觀看
#0545 Heterogeneity of [68Ga] Ga‑PSMA‑11 PET/CT in the assessment of therapy response in metastatic renal cell carcinoma treated with immune checkpoint inhibitors plus tyrosine kinase inhibitors
137 觀看
#0645 PSMA PET as a tool for Active Surveillance- Where are we at? Current Evidence and future directions
137 觀看
  • <
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • >
/ 163
地址:台北市 11051 信義區基隆路一段432號6樓之1, 電話:02-2729-0819, 傳真:02-2729-0864
網址: http://eschool.tua.org.tw,  EMail: eschool@tua.org.tw